| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.57B | -1.9% |
| Cost of Revenue | $718.5M | -2.3% |
| R&D Expense | $406.4M | -14.0% |
| SG&A Expense | $303.5M | -8.7% |
| Operating Income | $501.6M | +6.4% |
| Interest Expense | $153.0M | +30.2% |
| Pre-tax Income | $392.1M | +8.7% |
| Income Tax | $157.1M | +83.7% |
| Net Income | $235.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +34.0% |
| Accounts Receivable | $171.5M | +21.5% |
| Current Assets | $1.35B | +31.8% |
| Total Assets | $3.17B | +17.7% |
| Current Liabilities | $539.6M | +16.8% |
| Long-term Debt | $2.42B | +0.2% |
| Total Liabilities | $3.40B | +4.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $515.6M | +4.4% |
| Capital Expenditures | $32.6M | -52.3% |
| Investing Cash Flow | -$240.2M | -222.0% |
| Financing Cash Flow | -$18.2M | +97.2% |
| Free Cash Flow | $483.0M | +13.5% |
| -14.6% |
| EPS (Basic) | $0.64 | -7.2% |
| EPS (Diluted) | $0.64 | -7.2% |
| Stockholders' Equity |
| -$221.5M |
| +61.0% |